Sagimet Biosciences Inc. Series A
Ownership
Ownership Structure
Who owns Sagimet Biosciences Inc. Series A (SGMT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.6% of the shares are freely tradable; institutional investors hold 21.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Caligan Partners LP | 4.02 | 2,500,000 | +0.0 | 06/30/2026 |
| Affinity Asset Advisors, LLC | 4.02 | 2,497,864 | +187.8 | 06/30/2026 |
| Federated Hermes Inc | 3.36 | 2,086,715 | +267,085.0 | 06/30/2026 |
| Great Point Partners LLC | 3.27 | 2,029,933 | +0.0 | 06/30/2026 |
| Saturn V Capital Management LLC | 2.38 | 1,479,918 | +0.0 | 06/30/2026 |
| Blue Owl Capital Holdings LP | 2.03 | 1,260,544 | +277.5 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Federated Hermes Kaufmann Small Cap A | 3.35 | 2,083,333 | +0.0 | 06/30/2026 |
| Federated Hermes Kaufmann Small Cap Grow | 3.35 | 2,083,333 | +0.0 | 06/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.99 | 1,861,227 | +0.0 | 07/31/2026 |
| iShares Russell 2000 ETF | 2.37 | 1,475,032 | -0.6 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Happel David | President & CEO | 741,570 | 8,305,584 $ | Jul 20, 2026 | direct |
| Rozek Elizabeth | Chief Legal & Admin. Officer | 224,414 | 2,513,437 $ | Jul 20, 2026 | direct |
| Kemble George | Director | 62,161 | 696,203 $ | Aug 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Kemble George | Director | Sell | 350,987 | 10.23 | 3,591,580 |
| Aug 14, 2026 | Kemble George | Director | Other | 24,369 | 6.36 | 154,987 |
| Aug 14, 2026 | Kemble George | Director | Other | 326,618 | 6.36 | 2,077,290 |
| Aug 11, 2026 | Kemble George | Director | Sell | 20,206 | 9.95 | 201,147 |
| Aug 11, 2026 | Kemble George | Director | Other | 10,455 | 6.36 | 66,494 |
| Aug 11, 2026 | Kemble George | Director | Other | 9,751 | 6.36 | 62,016 |
| Jul 20, 2026 | Happel David | President & CEO | Sell | 64,051 | 7.76 | 497,068 |
| Jul 20, 2026 | Rozek Elizabeth | Chief Legal & Admin. Officer | Sell | 10,545 | 7.76 | 81,832 |
| Jul 20, 2026 | Kemble George | Director | Sell | 18,844 | 7.46 | 140,529 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.